Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #8693
Reference
MSAN(2026)15
Name
Ramipril 1.25mg capsules
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
Scotland
Health Boards
Supplies
Pharmaceutical Services
Description
There are intermittent supply issues with ramipril 1.25mg capsules until the end of May 2026.
Ramipril 1.25mg and 2.5mg tablets and ramipril oral solution remain available but cannot support increased demand.
A Serious Shortage Protocol (SSP) for ramipril 1.25mg capsules was issued on 22 April 2026. This SSP allows community pharmacists to limit supply to one month. Please refer to PCA(P)(2026)07 for further information.
Other low dose formulations of angiotensin-converting enzyme (ACE) inhibitors and angiotensin-II receptor blockers (ARBs) remain available, some of which can support increased demand.
Contact Name
Contact Email
Contact Address
Created
2026-04-28 13:37:00
Click to go back to homepage